RT @NephroUnimi: We don't have effective treatments for FSGS. In future studies, patient cohorts should be clearly defined to provide appro…
RT @NephroUnimi: We don't have effective treatments for FSGS. In future studies, patient cohorts should be clearly defined to provide appro…
RT @NephroUnimi: We don't have effective treatments for FSGS. In future studies, patient cohorts should be clearly defined to provide appro…
RT @NephroUnimi: We don't have effective treatments for FSGS. In future studies, patient cohorts should be clearly defined to provide appro…
RT @NephroUnimi: We don't have effective treatments for FSGS. In future studies, patient cohorts should be clearly defined to provide appro…
We don't have effective treatments for FSGS. In future studies, patient cohorts should be clearly defined to provide appropriate recommendations for primary, genetic or secondary FSGS. https://t.co/4mlf3xtcVP
RT @kdjhaveri: Interventions for focal segmental glomerulosclerosis in adults https://t.co/UL93WhuN45
RT @kdjhaveri: Interventions for focal segmental glomerulosclerosis in adults https://t.co/UL93WhuN45
RT @kdjhaveri: Interventions for focal segmental glomerulosclerosis in adults https://t.co/UL93WhuN45
Interventions for focal segmental glomerulosclerosis in adults https://t.co/UL93WhuN45
Immunosuppressive treatment for focal segmental glomerulosclerosis in adults https://t.co/1WRCs3j7yM Updated @CochraneKidney systematic review: 'limited info that #cyclosporin may ⬇️ protein in the urine but the data uncertain as studies enrolled too few p
New Review Update: Interventions for focal segmental glomerulosclerosis in adults. Discover the latest at #CochraneEvidence https://t.co/NGhuxJEppY #KidneyDisease https://t.co/EVHTPQxQfI